|View printer-friendly version|
|November 24, 2004 5:22 p.m.|
|Teva Announces Approval Of Cilostazol Tablets|
Jerusalem, Israel, November 24, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Cilostazol Tablets, 50 mg and 100 mg. Shipment of this product is expected to begin immediately.